Literature DB >> 29039121

Degradation of glycosphingolipids in oyster: ceramide glycanase and ceramidase in the hepatopancreas of oyster, Crassostrea virginica.

Nadejda V Pavlova1, Su-Chen Li1, Yu-Teh Li2.   

Abstract

The hepatopancreas of oyster, Crassostrea virginica, was found to contain two unique glycosphingolipid (GSL) cleaving enzymes, ceramide glycanase (CGase) and ceramidase. These two enzymes were found to be tightly associated together through the consecutive purification steps including gel filtration, hydrophobic interaction and cation-exchange chromatographies. They were separated only by preparatory SDS-PAGE. The purified CGase was found to have a molecular mass of 52 kDa and pH optimum of 3.2-3.3. This enzyme prefers to hydrolyze the acidic GSLs, II3SO3LacCer and gangliosides over the neutral GSLs. Oyster ceramidase was found to have a molecular mass of 88 kDa and pH optimum of 4-4.5. Since oyster ceramidase greatly prefers ceramides with C6 to C8 fatty acids, C6-ceramide (N-hexanoyl-D-sphingosine) was used as the substrate for its purification and characterization. The oyster acid ceramidase also catalyzed the synthesis of ceramide from a sphingosine and a fatty acid. For the synthesis, C16 and C18 fatty acids were the best precursors. The amino acid sequences of the two cyanogenbromide peptides derived from the purified ceramidase were found to have similarities to those of several neutral and alkaline ceramidases reported. The tight association of CGase and ceramidase may indicate that CGase in oyster hepatopancreas acts as a vehicle to release ceramide from GSLs for subsequent generation of sphingosines and fatty acids by ceramidase to serve as signaling factors and energy source.

Entities:  

Keywords:  CGase; Ceramidase; Glycolipids-cleaving enzyme; Oyster

Mesh:

Substances:

Year:  2017        PMID: 29039121     DOI: 10.1007/s10719-017-9802-7

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  35 in total

1.  Purification and characterization of a neutral ceramidase from mouse liver. A single protein catalyzes the reversible reaction in which ceramide is both hydrolyzed and synthesized.

Authors:  M Tani; N Okino; S Mitsutake; T Tanigawa; H Izu; M Ito
Journal:  J Biol Chem       Date:  2000-02-04       Impact factor: 5.157

2.  Purification and characterization of a novel ceramidase from Pseudomonas aeruginosa.

Authors:  N Okino; M Tani; S Imayama; M Ito
Journal:  J Biol Chem       Date:  1998-06-05       Impact factor: 5.157

3.  Enzymatic hydrolysis of sphingolipids. 8. Further purification and properties of rat brain ceramidase.

Authors:  E Yavin; S Gatt
Journal:  Biochemistry       Date:  1969-04       Impact factor: 3.162

4.  Cloning and characterization of a Saccharomyces cerevisiae alkaline ceramidase with specificity for dihydroceramide.

Authors:  C Mao; R Xu; A Bielawska; Z M Szulc; L M Obeid
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

5.  Simplified fluorometric assay for sphingosine bases.

Authors:  T J Higgins
Journal:  J Lipid Res       Date:  1984-09       Impact factor: 5.922

6.  Ceramide glycanase from the earthworm, Lumbricus terrestris.

Authors:  B Z Carter; S C Li; Y T Li
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

7.  Molecular cloning and characterization of a full-length complementary DNA encoding human acid ceramidase. Identification Of the first molecular lesion causing Farber disease.

Authors:  J Koch; S Gärtner; C M Li; L E Quintern; K Bernardo; O Levran; D Schnabel; R J Desnick; E H Schuchman; K Sandhoff
Journal:  J Biol Chem       Date:  1996-12-20       Impact factor: 5.157

8.  A novel enzyme that cleaves the N-acyl linkage of ceramides in various glycosphingolipids as well as sphingomyelin to produce their lyso forms.

Authors:  M Ito; T Kurita; K Kita
Journal:  J Biol Chem       Date:  1995-10-13       Impact factor: 5.157

9.  Ceramidase deficiency in Farber's disease (lipogranulomatosis).

Authors:  M Sugita; J T Dulaney; H W Moser
Journal:  Science       Date:  1972-12-08       Impact factor: 47.728

10.  Purification, characterization, and biosynthesis of human acid ceramidase.

Authors:  K Bernardo; R Hurwitz; T Zenk; R J Desnick; K Ferlinz; E H Schuchman; K Sandhoff
Journal:  J Biol Chem       Date:  1995-05-12       Impact factor: 5.157

View more
  1 in total

1.  Distinguishing the differences in β-glycosylceramidase folds, dynamics, and actions informs therapeutic uses.

Authors:  Fredj Ben Bdira; Marta Artola; Herman S Overkleeft; Marcellus Ubbink; Johannes M F G Aerts
Journal:  J Lipid Res       Date:  2018-10-02       Impact factor: 5.922

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.